InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Stein Jeffrey, Chief Executive Officer. Officer active across 2 companies, notably Cidara Therapeutics, Inc.. Cumulatively, 11 disclosures have been recorded. Total volume traded: €257k. The latest transaction was disclosed on 31 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations11 total
270 shares
Common Stock
SEC:0001478831-26-000004·
270 shares
Common Stock
SEC:0001478831-26-000004:0·
0165,000 shares0
Common Stock
SEC:0001610618-22-000023:0·
020,000 shares0
Common Stock
SEC:0000904454-22-000173·
020,000 shares0
Common Stock
SEC:0000904454-22-000173:0·
020,000 shares0
Common Stock
SEC:0001209191-22-002603·
020,000 shares0
Common Stock
SEC:0001209191-22-002603:0·
€69,45450,000 shares@ €1.389154.1% of flow
Common Stock
SEC:0001610618-21-000108·
Ideal exit: 9 Aug 2022 (T+270)
€69,45450,000 shares@ €1.389127.1% of flow
Common Stock
SEC:0001610618-21-000108:0·
Ideal exit: 9 Aug 2022 (T+270)
€58,85940,000 shares@ €1.471545.9% of flow
Common Stock
SEC:0001209191-21-052546·
Ideal exit: 15 May 2022 (T+270)
€58,85940,000 shares@ €1.471522.9% of flow
Common Stock
SEC:0001209191-21-052546:0·
Ideal exit: 15 May 2022 (T+270)
11 of 11 declarations
About Stein Jeffrey
Jeffrey Stein serves as Chief Executive Officer and Board Member at Cidara Therapeutics, Inc. and Paratek Pharmaceuticals, Inc. He oversees the strategic and operational direction of these companies, ensuring that growth objectives are met. Jeffrey has a strong background in the pharmaceutical sector, enabling him to effectively lead his teams towards operational excellence. His commitment to innovation and sustainability is central to his mission.
